CD39 Contributes to the Ability of Cell Invasion in Heterogeneity of Colorectal Cancer
Journal of Cellular and Molecular Medicine · 2025-03 · 29 (5)
DOI: 10.1111/jcmm.70486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 07.03.2025. Verfasst von Xiaosong Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Suzhou Ninth People's Hospital, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Apyrase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou Science and Technology Planning Project, Science and Technology Planning Fund of Affiliated Hospital of Xuzhou Medical University, Program of Developing Public Health through Science and Education of Wujiang District, Suzhou.
Abstract (Originalsprache)
Tumour heterogeneity will accumulate and amplify during cell culture and passage, even if derived from the same strain. In the current study, multiple batches of colorectal cancer HCT116 and HT29 cell lines were obtained using different conditions of trypsin digestion and processed for RNA sequencing. CD39 was identified as a biomarker highly expressed in easily trypsin‐digested cells compared to the undigestible ones. Furthermore, CD39 was determined to enhance cell invasion and suppress cell apoptosis but not affect cell proliferation. Moreover, CD39 could activate the TGF‐β/SMAD3 signalling pathway, whereas the expression of CD39 was negatively regulated by SMAD3 via recruitment of SETDB1 and adding H3K9me3 to the CD39 promoter in HCT116 cells. Overall, our study uncovered distinct gene signatures amongst different heterogeneities of colorectal cells and revealed the effect of CD39 on cell invasion and apoptosis, as well as determined the epigenetic role in regulating CD39 transcription.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Suzhou Ninth People's Hospital, Suzhou, Jiangsu, China.
- Central Laboratory, Suzhou Bay Clinical College, Suzhou Ninth People's Hospital, Xuzhou Medical University, Suzhou, Jiangsu, China.
ORCID-Profile: Yihang Shen
Förderung
- Suzhou Science and Technology Planning Project
- Science and Technology Planning Fund of Affiliated Hospital of Xuzhou Medical University
- Program of Developing Public Health through Science and Education of Wujiang District, Suzhou
- Jiangsu Province High-level Innovation and Entrepreneurship Talent Plan
- Suzhou Ninth People's Hospital Institutional-Level Project
- 2024 Provincial Traditional Chinese Medicine Society Research Project - Revitalization and Development Project
Zitieren
APA
Li, X., Shen, Y., Lang, J., Wu, J., Qian, Z., Shen, G., & Shen, Y. (2025). CD39 Contributes to the Ability of Cell Invasion in Heterogeneity of Colorectal Cancer. Journal of Cellular and Molecular Medicine, 29(5). https://doi.org/10.1111/jcmm.70486
Vancouver
Li X, Shen Y, Lang J, Wu J, Qian Z, Shen G, et al. CD39 Contributes to the Ability of Cell Invasion in Heterogeneity of Colorectal Cancer. Journal of Cellular and Molecular Medicine. 2025;29(5). doi:10.1111/jcmm.70486
BibTeX
@article{Li2025,
author = {Li, Xiaosong and Shen, Yifen and Lang, Jianhua and Wu, Jianzhong and Qian, Zhenhai and Shen, Genhai and Shen, Yihang},
title = {CD39 Contributes to the Ability of Cell Invasion in Heterogeneity of Colorectal Cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {5},
doi = {10.1111/jcmm.70486}
}
EUVIMED